Suchergebnisse - "Voulgari, Athina"

PubPharm (10)

1

Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer

enthalten in: Cancer | 2024

von Mutch, D. | Voulgari, A. | Chen, X. | +11

2

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation-Positive Advanced Melanoma : Extended Follow-up of the coBRIM Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Ascierto, P. | Dréno, B. | Larkin, J. | +17

3

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids : A randomized, placebo-controlled phase II trial (TREBLE)

enthalten in: Journal of the American Academy of Dermatology | 2018

von Simpson, E. | Flohr, C. | Eichenfield, L. | +11

4

Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis

enthalten in: Hepatology international | 2016

von Gane, E. | Rouzier, R. | Hassanein, T. | +10

5

Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis

enthalten in: Hepatology international | 2016

von Gane, E. | Rouzier, R. | Hassanein, T. | +10

6

Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis

enthalten in: Hepatology international | 2016

von Gane, E. | Rouzier, R. | Hassanein, T. | +10

7

Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis

enthalten in: Hepatology international | 2016

von Gane, E. | Rouzier, R. | Hassanein, T. | +10

8

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response : The Randomized DYNAMO 1 and DYNAMO 2 Studies

enthalten in: PloS one | 2016

von Wedemeyer, H. | Forns, X. | Hézode, C. | +6

9

DAUPHINE : a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2015

von Everson, G. | Cooper, C. | Hézode, C. | +15

CommentIn: Liver Int. 2014 Aug;34(7):e168-70. - PMID 24650101

10

Association of four DNA polymorphisms with acute rejection after kidney transplantation

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2008

von Grinyó, J. | Vanrenterghem, Y. | Nashan, B. | +9

1
[1]